))
132 – MALDI-TOF test for C. auris; FDA issues guidances for opioid use disorder; 510(k) clearance for beacon transponder used in lung SBRT
Archived series ("Inactive feed" status)
When?
This feed was archived on October 07, 2018 00:40 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 204053879 series 1587676
Content provided by Emma Nichols. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Emma Nichols or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
April 24, 2018
Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com
1:10 FDA authorizes new use of test, first to identify the emerging pathogen Candida auris https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm605336.htm
3:49 FDA encourages more widespread innovation and development of new treatments for opioid use disorder https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm605235.htm https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm605248.htm
7:25 Varian Calypso anchored beacon transponder for lung receives FDA 510k clearance https://www.prnewswire.com/news-releases/varian-calypso-anchored-beacon-transponder-for-lung-receives-fda-510k-clearance-300633354.html
Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.
Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
100 episodes
Share
